Cardiac Implications of COVID-19 in Deceased and Recovered Patients: A Systematic Review.

Publisher: Hindawi Pub. Corp Country of Publication: Egypt NLM ID: 101496545 Publication Model: eCollection Cited Medium: Print ISSN: 1687-708X (Print) Linking ISSN: 1687708X NLM ISO Abbreviation: Interdiscip Perspect Infect Dis Subsets: PubMed not MEDLINE

Original Publication: [Cairo] : Hindawi Pub. Corp.

Background: Patients infected with coronavirus disease 2019 (COVID-19) present with various clinical presentations with majority of them developing pulmonary complications. This study focuses on cardiac implications of COVID-19 which are less discussed and thus will help to address cardiac implications of COVID-19.
Methods: PubMed, PubMed Central, and Google Scholar were screened for articles which mentioned cardiac implications of COVID-19. NHLBI Study Quality Assessment Tools for the observational cohort and cross-sectional studies was used for assessing the risk of bias of our studies.
Results: All 14 studies selected were good and had score of ≥9 by NHLBI Study Quality Assessment Tools. Cardiac complications of COVID-19 are common. They are associated with significant mortality. Also, people infected with COVID-19 with premorbid conditions such as cardiovascular diseases and diabetes mellitus have poor prognosis as compared to those without premorbid conditions. Cardiac biomarkers such as highly sensitive troponin I, creatinine, and creatinine kinase-MB on admission are good prognostic markers.
Conclusions: Cardiac complications such as heart failure, myocardial injury, and arrhythmias are common among patients infected with COVID-19. Elevated cardiac markers and patients with cardiac complications require utmost care and continuous cardiac monitoring.
Competing Interests: The authors declare that they have no conflicts of interest.
(Copyright © 2022 Rajaram Khanal et al.)

Eur Heart J. 2020 Jun 7;41(22):2070-2079. (PMID: 32391877)
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
J Cardiovasc Electrophysiol. 2020 May;31(5):1003-1008. (PMID: 32270559)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Tohoku J Exp Med. 2020;252(1):73-84. (PMID: 32908083)
Emerg Infect Dis. 2016 Jan;22(1):49-55. (PMID: 26692185)
Thorax. 2018 Mar;73(3):286-289. (PMID: 28724637)
J Clin Epidemiol. 2009 Oct;62(10):e1-34. (PMID: 19631507)
Eur Heart J Case Rep. 2020 Nov 24;4(6):1-2. (PMID: 33447716)
Biomed Res Int. 2020 Oct 5;2020:2138387. (PMID: 33029494)
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. (PMID: 32209890)
J Biol Regul Homeost Agents. 2020 Apr 07;34(2):339-343. (PMID: 32253888)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
J Card Surg. 2020 Aug;35(8):1988-2008. (PMID: 32652713)
J Crit Care. 2020 Dec;60:32-37. (PMID: 32736197)
Clin Res Cardiol. 2020 May;109(5):531-538. (PMID: 32161990)
Appl Soft Comput. 2021 Sep;108:107449. (PMID: 33967657)
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212. (PMID: 32172175)
J Clin Med. 2020 Jul 18;9(7):. (PMID: 32708357)
Crit Care. 2020 Apr 30;24(1):188. (PMID: 32354360)
Am J Otolaryngol. 2020 Sep - Oct;41(5):102581. (PMID: 32563019)
Intensive Care Med. 2020 Oct;46(10):1863-1872. (PMID: 32816098)
CMAJ. 2020 Jul 13;192(28):E791-E798. (PMID: 32586839)
Intern Emerg Med. 2020 Nov;15(8):1457-1465. (PMID: 32960429)
BMJ. 2020 Mar 26;368:m1091. (PMID: 32217556)
Ann Intern Med. 2003 Nov 4;139(9):715-23. (PMID: 14597455)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Infect Dis Poverty. 2020 Mar 17;9(1):29. (PMID: 32183901)
Biomed Res Int. 2021 Jun 19;2021:9995073. (PMID: 34250095)
J Infect Public Health. 2020 Dec;13(12):1833-1839. (PMID: 32788073)
Am J Emerg Med. 2021 Aug;46:204-211. (PMID: 33071085)
Chaos Solitons Fractals. 2020 Nov;140:110170. (PMID: 32834651)

Date Created: 20220620 Latest Revision: 20220716

20240105

PMC9204499

10.1155/2022/9119930

35722221